Frost & Sullivan Rhenu Bhuller provides insight into Malaysia’s healthcare industry positioning in the Southeast Asian region and the ability to provide affordable quality healthcare in a country that is naturally diverse as an important competitive advantage. The pharmaceutical sector has been the fastest growing industry in Malaysia between 2000 and 2009,…
Biotech The CEO of Venter Pharma explains the challenges of bringing a diagnostic drug to the market, and how they hope to leverage the science behind their product, LacTEST, in various new forms and indications. Before you came on board at Venter Pharma, the research for your product LacTEST was…
adherence Adherence solutions company Atlantis Healthcare founded its Spanish affiliate in 2010. Ana Maria Arboleda, managing director, discusses adherence issues in Spain and efforts to ensure that patients remain committed to their medication treatment. What was the inspiration for creating Atlantis Healthcare in Spain? 15 years ago, we had a…
pricing Cho Chan-Hwui, president of the Korean Pharmaceutical Association (KPA), discusses the major hurdles that pharmacists in Korea must overcome today, and the increased focus on prescription by INN. How successfully has the policy stipulating the separation of prescription and dispensing (SPD) worked over the last 15 years? Complete success…
innovation Hakim Djaballah arrived to Institut Pasteur Korea in July 2014 with an aim to return to the French institute’s focus on infectious diseases. He outlines the complexities of Korea’s research industry and stresses the importance of knowledge-sharing for success. What have been some of the most important changes made…
innovation Dr. Jung Yun-Taek, head researcher of the pharmaceutical division at the Korea Health Industry Development Institute (KHIDI), discusses the real potential that Korean pharmaceutical companies offer to the rest of the world for disruptive and incremental innovation. What are the current trends in Korea’s pharmaceutical industry? The global market…
entrepreneurship Mauro Bono discusses the challenges of building a company from the interior of Argentina, and shares his assessment of the key issues driving and preventing change in the country’s pharmaceutical sector. What are some of the challenges and opportunities associated with building a business in Cordoba, given that Argentina’s…
biotech The executive director and general manager of Amgen Mexico discusses how the company relies on Mexico as a hub for clinical research, with an investment of over USD 22 million since 2006, and strives to deliver its pipeline of innovative medicines to treat seriously ill patients in Mexico. You…
association On behalf of the chamber of industry that represents research-based pharma and biopharma companies in Argentina, Ernesto Felicio discusses the current challenges facing the industry, and the chambers current agenda for change. To what extent has the environment for multinationals, or their role in the Argentinian pharmaceutical industry, significantly…
innovation The general manager of BI Algeria discusses how Algeria could benefit from participating in international clinical trials and describes how his company is adapting its offering to mirror the changing health profile of the nation which is currently undergoing a transition from infectious and transmissible disease to chronic and lifestyle illnesses.…
research The director general for Scientific Research and Technological Development discusses the authorities’ efforts to incentivize R&D and to harmonize sectoral development strategies to achieve national economic growth outcomes. He also identifies bottlenecks in the human capital base and the importance of raising the intellectual and scientific level of the local…
See our Cookie Privacy Policy Here